Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Kidney International

• Publication date

  2012-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ki.2011.415PMID 22166848PMCID PMC4641306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

  2011cited by this paper
• Effects of intensive blood-pressure control in type 2 diabetes mellitus.

  2010cited by this paper
• Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

  2010cited by this paper
• Erratum: Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial (The Lancet (2010) 376 (419-430))

  2010cited by this paper
• Effects of medical therapies on retinopathy progression in type 2 diabetes.

  2010cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes

  2009cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008influential reference
• Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

  2007cited by this paper
• Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

  2007cited by this paper
• Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

  2007cited by this paper
• Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75)

  2006cited by this paper
• Risk Factors for Renal Dysfunction in Type 2 Diabetes

  2006cited by this paper
• Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

  2003cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

  2000cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Patterns of renal injury in NIDDM patients with microalbuminuria

  1996cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

  1995cited by this paper
• Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy.

  1994cited by this paper
• The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.

  1994cited by this paper
• Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients.

  1992cited by this paper
• Effects of mid-point imputation on the analysis of doubly censored data.

  1992cited by this paper

• Novel Visceral Obesity Indicators and Associated Metabolic Fingerprint in Incident Diabetic Retinopathy

  2025cites this paper
• Evaluating the Renal Implications of Intensive Versus Standard Blood Pressure Control in Chronic Kidney Disease: A Systematic Review of Randomized Trials

  2025cites this paper
• Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.

  2025cites this paper
• Relation between vitamin D deficiency and diabetic maculopathy

  2025cites this paper
• Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis

  2025cites this paper
• Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology

  2024cites this paper
• Blood pressure control for diabetic retinopathy.

  2023cites this paper
• The Relationship between Vascular Aging Phenotypes and Renal Damage among Individuals with Type 2 Diabetes

  2023cites this paper
• The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW‐CKD

  2023cites this paper
• COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?

  2022cites this paper
• The Effect of Allopurinol on Renal Outcomes in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study

  2022cites this paper
• Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021

  2022cites this paper
• Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes

  2021cites this paper
• Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk

  2021cites this paper
• Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

  2020cites this paper
• The Relationship Between Lipid Metabolism and The Level of Albuminuria with Single Nucleotide Polymorphism -204A>C [rs 3808607] CYP7A1 Gene in Patients with Type 2 Diabetes Mellitus and Diabetic Nephropathy

  2019cites this paper
• Diabetic Nephropathy

  2019cites this paper
• Preventing the development and progression of diabetic kidney disease: Where do we stand?

  2018cites this paper
• Controlo intensivo da pressão arterial na diabetes mellitus tipo 2: qual a evidência?

  2018cites this paper
• Microvascular Damage and Hemodynamic Alterations in Diabetic Nephropathy

  2018cites this paper
• Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach

  2018cites this paper
• Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials.

  2018cites this paper
• Intensive systolic blood pressure control and incident chronic kidney disease in persons with and without diabetes mellitus: Secondary analyses of two randomized controlled trials

  2018cites this paper
• Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study

  2018cites this paper
• Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

  2018cites this paper
• Combined effect of glycemic and blood pressure control on diabetic retinopathy among Chinese with type-2 diabetes mellitus

  2018cites this paper
• Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Diagnosis and Management of Type 2 Diabetic Kidney Disease.

  2017cites this paper
• Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes

  2017cites this paper
• Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New.

  2017cites this paper
• Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2017cites this paper
• Glucose targets for preventing diabetic kidney disease and its progression.

  2017cites this paper
• Prevalence of chronic kidney disease stages 3-5 among patients with type 2 diabetes mellitus in Bangladesh

  2017cites this paper
• HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women: A 9years follow-up study.

  2017cites this paper
• Sodium glucose transporter‐2 inhibition has no renoprotective effects on non‐diabetic chronic kidney disease

  2017cites this paper
• Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study

  2017cites this paper
• Use of ACE inhibition and blood pressure management in deferring dialysis initiation.

  2017cites this paper
• Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study

  2017cites this paper
• Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME.

  2017influential citation
• Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes

  2016cites this paper
• Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes

  2016cites this paper
• Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.

  2016cites this paper
• Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy

  2016cites this paper
• Improved incidence of end-stage renal disease of type 1 diabetes in Japan, from a hospital-based survey

  2016cites this paper
• Reverse Translational Study of Fenofibrate's Observed Effects in Diabetes‐Associated Retinopathy

  2016cites this paper
• Intensive versus Standard Therapy for Hypertension: The Clinical Trials

  2016cites this paper
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

  2015cites this paper
• Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation

  2015cites this paper
• Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

  2015cites this paper
• Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

  2014cites this paper
• Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysis.

  2014cites this paper
• Blood pressure control for diabetic retinopathy

  2014cites this paper
• Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial

  2014cites this paper
• Diabetes: treating hypertension.

  2014cites this paper
• Blood Pressure and Pulse Pressure Effects on Renal Outcomes in the Veterans Affairs Diabetes Trial (VADT)

  2014cites this paper
• The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?

  2014cites this paper
• Diagnosis and Treatment of Diabetic Kidney Disease

  2014cites this paper
• Do Cardiac Biomarkers NT-proBNP and hsTnT Predict Microvascular Events in Patients With Type 2 Diabetes? Results From the ADVANCE Trial

  2014cites this paper
• Albuminuria and cognitive decline in people with diabetes and normal renal function.

  2013cites this paper
• Between Remission of Macroalbuminuria and Preservation of Renal Function i n Patients With Typ e 2 Diabetes Mellitus With Overt Proteinuria

  2013cites this paper
• HbA1c targets in type 2 diabetes: guidelines and evidence

  2013cites this paper
• Association Between Remission of Macroalbuminuria and Preservation of Renal Function in Patients With Type 2 Diabetes With Overt Proteinuria

  2013cites this paper
• Vitamin D and Diabetic Neuropathy

  2013cites this paper
• American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement

  2013cites this paper
• MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.

  2013cites this paper
• [Diabetes and the kidneys].

  2012cites this paper
• Effect of Intensive Versus Standard Blood Pressure Control on Depression and Health-Related Quality of Life in Type 2 Diabetes

  2012cites this paper
• Diabetes: Glycemic and blood-pressure control—lower is not better

  2012cites this paper
• Full Review Systems biology: Building a useful model from multiple markers and pro fi les

  2012cites this paper
• Diabetes und Niere

  2012cites this paper
• Systems biology: building a useful model from multiple markers and profiles.

  2012cites this paper
• Diabetes: East meets West. The Joint American Association of Clinical Endocrinologists‐Chinese Society of Endocrinology (AACE‐CSE) Symposium

  2012cites this paper
• Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).

  2012cites this paper